| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A lesson to learn from dolutegravir roll-out
|
The Lancet HIV,
|
|
2019
|
6 |
9 |
p. e559
|
artikel
|
| 2 |
Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study
|
Scarsi, Kimberly K
|
|
2019
|
6 |
9 |
p. e601-e612
|
artikel
|
| 3 |
Correlates of HIV infection in adolescent girls and young women in Lesotho: results from a population-based survey
|
Low, Andrea
|
|
2019
|
6 |
9 |
p. e613-e622
|
artikel
|
| 4 |
Dolutegravir–rilpivirine for virological suppression
|
Pozniak, Anton L
|
|
2019
|
6 |
9 |
p. e560-e561
|
artikel
|
| 5 |
Drug interactions: not just for orally administered drugs
|
Chappell, Catherine A
|
|
2019
|
6 |
9 |
p. e563-e564
|
artikel
|
| 6 |
Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies
|
Aboud, Michael
|
|
2019
|
6 |
9 |
p. e576-e587
|
artikel
|
| 7 |
Fighting HIV/AIDS from Ghana's pulpits
|
Adepoju, Paul
|
|
2019
|
6 |
9 |
p. e573
|
artikel
|
| 8 |
Gender on show
|
Burki, Talha
|
|
2019
|
6 |
9 |
p. e574-e575
|
artikel
|
| 9 |
Ghana's goal to end MTCT of HIV by 2020
|
Adepoju, Paul
|
|
2019
|
6 |
9 |
p. e570-e571
|
artikel
|
| 10 |
Have clinical trials in HIV finally matured?
|
Mills, Edward J
|
|
2019
|
6 |
9 |
p. e561-e563
|
artikel
|
| 11 |
Highlights from the 10th IAS Conference on Science
|
Hayward, Peter
|
|
2019
|
6 |
9 |
p. e572
|
artikel
|
| 12 |
Men, migration, mothers, and HIV risk in adolescent girls
|
Ferrand, Rashida A
|
|
2019
|
6 |
9 |
p. e565-e566
|
artikel
|
| 13 |
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list
|
Penazzato, Martina
|
|
2019
|
6 |
9 |
p. e623-e631
|
artikel
|
| 14 |
The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment
|
Baral, Stefan
|
|
2019
|
6 |
9 |
p. e632-e638
|
artikel
|
| 15 |
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
|
Grinsztejn, Beatriz
|
|
2019
|
6 |
9 |
p. e588-e600
|
artikel
|
| 16 |
Transgender HIV research: nothing about us without us
|
Scheim, Ayden I
|
|
2019
|
6 |
9 |
p. e566-e567
|
artikel
|
| 17 |
Use of doxycycline prophylaxis among gay and bisexual men in Melbourne
|
Chow, Eric P F
|
|
2019
|
6 |
9 |
p. e568-e569
|
artikel
|
Tijdschrift beschrijving